Physician profile
Valsa John
NPI 1700955481
$3,493.83
in general payments reported to CMS, 2019-2025
18 companies · $837 in 2025
The $837 reported for 2025 was more than what 82% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $987 · 2022: $541 · 2023: $581 · 2024: $547 · 2025: $837.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,965.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $700.14 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $618.85 | 2021-2025 | |
| Dexcom, INC. | $486.64 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $406.86 | 2022-2024 | |
| Abbott Laboratories | $353.20 | 2024-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $352.33 | 2022-2025 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.56 | 2021-2023 | Jardiance, Synjardy, Tradjenta |
| Lilly USA, LLC | $91.20 | 2022-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $87.83 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Kowa Pharmaceuticals America, INC. | $38.01 | 2025 | Zoryve |
| Pfizer INC. | $36.22 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $34.33 | 2021-2023 | |
| Amgen INC. | $25.73 | 2025 | Krystexxa |
| Xeris Pharmaceuticals, INC. | $24.32 | 2025 | Gvoke Hypopen |
| Shield Therapeutics INC | $22.16 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $22.15 | 2024 | Jynarque |
| Ani Pharmaceuticals, INC. | $22.06 | 2025 | Purified Cortrophin Gel |
| Phathom Pharmaceuticals, INC. | $17.24 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Valsa John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.